Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
New institute brings together Evonik’s most advanced biotech platform and a global network of evaluation labs
It is the first autotaxin inhibitor to be investigated in cancer patients
The institution will be spread over an area of more than 8 acres
Women emerge as the cornerstone of this monumental undertaking
The product combines proven efficacy of Doxylamine succinate 20 mg and Pyridoxine hydrochloride 20 mg in an Extended Release formulation
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
The WHO GMP approved vertically integrated ONCOLOGY unit of SAKAR has been selling products nationally since few quarters
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
Uppilliappan joined Dr. Lal Pathlabs in 2016 as Chief Operating Officer and later became CEO
Subscribe To Our Newsletter & Stay Updated
